For RNA extraction blood samples were collected in
Tempus Blood RNA Tubes (Applied Biosystems, Foster City, CA, USA) and stored at −80 °C. RNA was extracted according to the manufacturer’s instructions. The RNA concentration was determined for each sample prior to reverse transcription using
NanoDrop One (ThermoScientific, Whaltham, MA 02451, USA). Reverse transcription reactions were performed using 4 µL of the 5× FastGene
® Scriptase II ReadyMix (Nippon Genetics, Duren, Germany) and 100 ng of RNA for each reaction. Reactions were carried out in a CFX90 cycler (BioRad, Hercules, CA, USA) at the following conditions: 25 °C for 10 min, 42 °C for 60 min and 85 °C for 5 min. Real time PCR reactions were carried out in a CFX90 cycler. Each reaction consisted of 1 μL primer-probe assay mix (IDT, Coralville, IA, USA), 10 μL Luna Master Mix (Biolabs, Waltham, MA, USA) and 1 μL cDNA. The GAPDH was used as a housekeeping gene for data normalization. The sequences for the Real time PCR primers and probes for HO-1 mRNA were as follows: forward primer: 5′-GTT CCT CAT GAA CTC AGC ATT-3′, reverse primer: 5′-GAG CCA GCA CGA ACG AG-3′, probe: 56-FAM/AGC ATG CCC /ZEN/CAG GAT TTG TCA GA/3IABkFQ. Reactions were carried out in triplicate and results were analysed by the ΔΔCT method
Detsika M.G., Nikitopoulou I., Veroutis D., Vassiliou A.G., Jahaj E., Tsipilis S., Athanassiou N., Gakiopoulou H., Gorgoulis V.G., Dimopoulou I., Orfanos S.E, & Kotanidou A. (2022). Increase of HO-1 Expression in Critically Ill COVID-19 Patients Is Associated with Poor Prognosis and Outcome. Antioxidants, 11(7), 1300.